Heterogeneity in diphtheria-tetanus-acellular pertussis vaccine-specific cellular immunity during infancy: Relationship to variations in the kinetics of postnatal maturation of systemic Th1 function

Journal of Infectious Diseases

Volumn 184, Issue 1, 2001, Pages 80-88

  Rowe, J ^a   Macaubas, C ^a   Monger, T ^a   Holt, B J ^a   Harvey, J ^a   Poolman, J T ^c   Loh, R ^b   Sly, P D ^a   Holt, P G ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^c GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DIPHTHERIA PERTUSSIS TETANUS VACCINE; GAMMA INTERFERON; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; INTERLEUKIN 13; INTERLEUKIN 5; MEASLES MUMPS RUBELLA VACCINE; ORAL POLIOMYELITIS VACCINE; TETANUS TOXOID;

ARTICLE; BACTERIAL INFECTION; CELLULAR IMMUNITY; DIPHTHERIA; HEPATITIS B; HUMAN; HUMAN CELL; IMMUNIZATION; INFANT; INFANT DISEASE; MAJOR CLINICAL STUDY; MEASLES; MUMPS; PERTUSSIS; POLIOMYELITIS; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RUBELLA; TETANUS; TH1 CELL; VACCINATION; VIRUS INFECTION;

COHORT STUDIES; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFANT; KINETICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TH1 CELLS; TH2 CELLS;

EID: 0035400061     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/320996     Document Type: Article

References (42)

1. Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines
2. Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis
3. Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Stage II Working Group
4. Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines
5. Vaccine and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines
6. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children
7. Cytokine mRNA expression and proliferative responses induced by pertussis toxin, filamentous hemagglutinin, and pertactin of Bordetella pertussis in the peripheral blood mononuclear cells of infection and immunized schoolchildren and adults
8. Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine
9. Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine
10. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: Predominance of a Th2-biased pattern which persists alter adult boosting
11. Protection against Bordetella pertussis in mice in the absence of circulating antibody: Implications for long term immunity in children
12. Cell-mediated immunity to Bordetella pertussis: Role of Th1 cells in bacterial clearance in a murine respiratory infection model
13. Immunity in early life
14. Activation and functional capacity of human neonatal CD4 T cells
15. T-cell function in newborn mice and humans
16. Development of immunologic memory against tetanus toxoid and pertactin antigens from the diphtheria-tetanus-pertussis vaccine in atopic versus nonatopic children
17. Antigen-specific responses to diphtheria-tetanus-acellular pertussis vaccine in human infants are initially Th2 polarized
18. Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens
19. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a Th2 phenomenon?
20. Genetic "risk" for atopy is associated with delayed postnatal maturation of T-cell competence
21. Development of long term tolerance versus sensitization to environmental allergens during the perinatal period
22. Transplacental priming of the human immune system to environmental allergens: Universal skewing of initial T-cell responses towards the Th-2 cytokine profile
23. Inhalant allergen-specific T-cell reactivity is detectable in close to 100% of atopic and normal individuals: Covert responses are unmasked by serum-free medium
24. Regulation of Th-cell responses to inhalant allergen during early childhood
25. Th-2-polarized immunological memory to inhalant allergens in atopics is established during infancy and early childhood
26. T helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resportions
27. Expansion of memory Th2 cells over Th1 cells in neonatal primed mice
28. Enhanced type 2 and diminished type 1 cytokines in neonatal tolerance
29. Synthesis of T helper 2-type cytokines at the maternal-fetal interface
30. Impaired production of γ-interferon by newborn cells in vitro is due to a functionally immature macrophage
31. Decreased production of interferon gamma by human neonatal cells: Intrinsic and regulatory deficiencies
32. Partial correction of the Th2/Th1 imbalance in neonatal murine responses to vaccine antigens through selective adjuvant effects
33. Localization of Th-cell subsets in inflammation: Differential thresholds for extravasation of Th1 and Th2 cells
34. Postnatal maturation of immune competence during infancy and early childhood
35. Neonatal tolerance revisited: Turning on newborn T cells with dendritic cells
36. Newborns develop a Th1-type immune response to Mycobacterium boris bacillus Calmette-Guérin vaccination
37. Inverse association between tuberculin responses and atopic disorder
38. Raised serum IgE associated with reduced responsiveness to DPT vaccination during infancy
39. Atopic eczema is associated with delayed maturation of the antibody response to pneumococcal vaccine
40. Reduced interferon-γ expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease
41. Decreased interleukin-12 levels in umbilical cord blood in children who developed acute bronchiolitis
42. IL-12 is required for the maintenance of IFN-γ production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii